Skip to main content
Clinical Trials/NCT06746571
NCT06746571Not yet recruitingNot Applicable

Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients

Sohag University2 sites in 1 country100 target enrollmentStarted: January 15, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
100
Locations
2
Primary Endpoint
neutrophil to lymphocyte ratio

Study Overview

Brief Summary

Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Detailed Description

Role of neutrophil to lymph ratio , lymphocyte to monocyte ratio and platelet to lymphocyte in acute lymphoblastic leukemia adults and pediatric patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Crossover
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
5 Years to 50 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients newly diagnosed ALL

Exclusion Criteria

  • others malignanices
  • ALL on therapy

Outcomes

Primary Outcomes

neutrophil to lymphocyte ratio

Time Frame: 1 year

count of neutophils comparing lymphocytees

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Omnia Aly Mohamed

resident-clinical pathology sohag university hospital

Sohag University

Study Sites (2)

Loading locations...

Similar Trials

Role of Cbc Indices in Acute Lymphoblastic... | Clinical Trial